FOLH1 and hepatocellular carcinoma: A previous systematic review published by Dondi et al. investigated the role of PSMA-targeting radiopharmaceuticals in detecting HCC lesions [56] and did not provide quantitative analyses; furthermore, it included less original articles and some case reports.